These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 1517225

  • 1. Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps.
    Jeang KT, Berkhout B.
    J Biol Chem; 1992 Sep 05; 267(25):17891-9. PubMed ID: 1517225
    [Abstract] [Full Text] [Related]

  • 2. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
    Tiley LS, Madore SJ, Malim MH, Cullen BR.
    Genes Dev; 1992 Nov 05; 6(11):2077-87. PubMed ID: 1427073
    [Abstract] [Full Text] [Related]

  • 3. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
    Chowdhury M, Taylor JP, Chang CF, Rappaport J, Khalili K.
    J Virol; 1992 Dec 05; 66(12):7355-61. PubMed ID: 1331525
    [Abstract] [Full Text] [Related]

  • 4. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L, Morris GF, Lockyer JM, Lu M, Wang Z, Morris CB.
    Virology; 1997 Aug 18; 235(1):48-64. PubMed ID: 9300036
    [Abstract] [Full Text] [Related]

  • 5. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.
    Kato H, Sumimoto H, Pognonec P, Chen CH, Rosen CA, Roeder RG.
    Genes Dev; 1992 Apr 18; 6(4):655-66. PubMed ID: 1559613
    [Abstract] [Full Text] [Related]

  • 6. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR.
    Proc Natl Acad Sci U S A; 1999 Jul 06; 96(14):7791-6. PubMed ID: 10393900
    [Abstract] [Full Text] [Related]

  • 7. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.
    Luo Y, Madore SJ, Parslow TG, Cullen BR, Peterlin BM.
    J Virol; 1993 Sep 06; 67(9):5617-22. PubMed ID: 8350414
    [Abstract] [Full Text] [Related]

  • 8. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J.
    J Virol; 1996 Sep 06; 70(9):5777-85. PubMed ID: 8709193
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T, Kaushik N, Pandey PK, Kashanchi F, Deng L, Pandey VN.
    Biochemistry; 2000 Sep 26; 39(38):11532-9. PubMed ID: 10995220
    [Abstract] [Full Text] [Related]

  • 10. A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA.
    Hart CE, Saltrelli MJ, Galphin JC, Schochetman G.
    J Virol; 1995 Oct 26; 69(10):6593-9. PubMed ID: 7666565
    [Abstract] [Full Text] [Related]

  • 11. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
    Wu F, Garcia J, Sigman D, Gaynor R.
    Genes Dev; 1991 Nov 26; 5(11):2128-40. PubMed ID: 1936997
    [Abstract] [Full Text] [Related]

  • 12. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
    Roebuck KA, Rabbi MF, Kagnoff MF.
    AIDS; 1997 Feb 26; 11(2):139-46. PubMed ID: 9030359
    [Abstract] [Full Text] [Related]

  • 13. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
    Ghosh S, Selby MJ, Peterlin BM.
    J Mol Biol; 1993 Dec 05; 234(3):610-9. PubMed ID: 8254663
    [Abstract] [Full Text] [Related]

  • 14. Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1.
    Alonso A, Cujec TP, Peterlin BM.
    J Virol; 1994 Oct 05; 68(10):6505-13. PubMed ID: 8083988
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.
    J Virol; 1993 May 05; 67(5):2853-61. PubMed ID: 8386279
    [Abstract] [Full Text] [Related]

  • 16. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
    García-Martínez LF, Mavankal G, Peters P, Wu-Baer F, Gaynor RB.
    J Mol Biol; 1995 Dec 01; 254(3):350-63. PubMed ID: 7490754
    [Abstract] [Full Text] [Related]

  • 17. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
    Tao J, Frankel AD.
    Proc Natl Acad Sci U S A; 1993 Feb 15; 90(4):1571-5. PubMed ID: 8434019
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
    Arzumanov A, Walsh AP, Rajwanshi VK, Kumar R, Wengel J, Gait MJ.
    Biochemistry; 2001 Dec 04; 40(48):14645-54. PubMed ID: 11724578
    [Abstract] [Full Text] [Related]

  • 19. The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA.
    Delling U, Roy S, Sumner-Smith M, Barnett R, Reid L, Rosen CA, Sonenberg N.
    Proc Natl Acad Sci U S A; 1991 Jul 15; 88(14):6234-8. PubMed ID: 2068104
    [Abstract] [Full Text] [Related]

  • 20. Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.
    Gatignol A, Duarte M, Daviet L, Chang YN, Jeang KT.
    Gene Expr; 1996 Jul 15; 5(4-5):217-28. PubMed ID: 8723388
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.